SCHEMBL19310127

SCHEMBL19310127

Bc1c(N)c2c(c(B)c1F)C(=O)N(C1C(=O)NC(=O)C(B)(B)C1(B)O)C2(B)B

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21927071 1.00 — —
SCHEMBL21924013 0.88 — —
SCHEMBL22199343 0.83 — —
SCHEMBL19310202 0.83 — —
SCHEMBL22199259 0.83 — —
SCHEMBL19309955 0.78 — —
SCHEMBL19310036 0.78 — —
SCHEMBL19309956 0.77 — —
SCHEMBL19310169 0.71 CRBN (0.47) —
SCHEMBL22199321 0.68 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3214081-B1 ISOINDOLINE DERIVATIVE, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF KANGPU BIOPHARMACEUTICALS LTD (CN) 2020-07-08 — — EP disclosed
EP-3214081-A1 ISOINDOLINE DERIVATIVE, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF Kangpu Biopharmaceuticals, Ltd. (CN) 2017-09-06 — — EP disclosed
Send feedback